An Open-label Study To Evaluate Plasma and Pulmonary Pharmacokinetics Following Intravenous Administration of GSK2140944 in Healthy Adult Subjects (BTZ116666)
Latest Information Update: 06 Jan 2024
At a glance
- Drugs Gepotidacin (Primary)
- Indications Gonorrhoea; Respiratory tract infections; Skin and soft tissue infections
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 13 Feb 2014 According to ClinicalTrials.gov record, status changed from active no longer recruiting to completed.
- 16 Jan 2014 According to ClinicalTrials.gov record, status changed from recruiting to active,no longer recruiting .
- 16 Jan 2014 According to ClinicalTrials.gov record, planned End Date changed from 1 Dec 2013 to 1 Jan 2014.